Showing results (381-390 of 1,787) with videos related to

Sort By:
Pageof 179
Hepatology Communications|December 6, 2023
IL-2 produced by HBV-specific T cells as a biomarker of viral control and predictor of response to PD-1 therapy across clinical phases of chronic hepatitis BConan Chua, Loghman Salimzadeh, Ann T Ma, et al.
Hepatology Communications|January 22, 2024
Modulation of canonical Wnt signaling regulates peribiliary mesenchymal identity during homeostasis and injurySerrena Singh, Tifanny Budiman, David Redmond, et al.
Hepatology Communications|March 11, 2024
[18F]AlF-ND-bisFAPI PET imaging of fibroblast activation protein as a biomarker to monitor the progression of liver fibrosisHongsheng Li, Ruoxue Dai, Yueqi Huang, et al.
Hepatology Communications|March 11, 2024
Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut microbiotaHao Yang, Qingqing Liu, Haixia Liu, et al.
Hepatology Communications|March 18, 2024
Therapeutic targeting at genome mutations of liver cancer by the insertion of HSV1 thymidine kinase through Cas9-mediated editingMuhamuda Kader, Wei Sun, Bao-Guo Ren, et al.
Hepatology Communications|March 18, 2024
The Edmonton Symptom Assessment System is a valid, reliable, and responsive tool to assess symptom burden in decompensated cirrhosisJohn Donlan, Chengbo Zeng, Teresa Indriolo, et al.
Hepatology Communications|March 18, 2024
ER stress promotes mitochondrial calcium overload and activates the ROS/NLRP3 axis to mediate fatty liver ischemic injuryFei Li, Zhu Guan, Yiyun Gao, et al.
Hepatology Communications|March 18, 2024
Clinical criteria accurately diagnose severe but not moderate alcohol-associated hepatitis: A systematic review and meta-analysisNipun Verma, Rohit Mehtani, Jacob Martin Haiar, et al.
Hepatology Communications|February 15, 2024
The role of sinusoidal endothelial cells and TIMP1 in the regulation of fibrosis in a novel human liver 3D NASH modelSander van Riet, Anais Julien, Andrea Atanasov, et al.
Hepatology Communications|February 15, 2024
Increased type-I interferon level is associated with liver damage and fibrosis in primary sclerosing cholangitisRebekka J S Salzmann, Christina Krötz, Tudor Mocan, et al.
Pageof 179